Men-Fang Shaio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Men-Fang Shaio has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Kuender D. Yang
2 shared publicationsChung-Shinn Lee
Departments of Pediatrics, Parasitology and Tropical Medicine National Defense Medical Center , Taipei, Taiwan, Republic of China
1 shared publicationHau Chuangb
1 shared publicationJia- Tsong Janc
1 shared publication- Kuender D. Yang
Chang Gung Children's Hospital at Kaohsiung, Chang Gung University, Kaohsiung, Taiwan
1 shared publication Meng-Ling Chu
Departments of Pediatrics, Parasitology and Tropical Medicine National Defense Medical Center , Taipei, Taiwan, Republic of China
1 shared publication
Latest Publications
- 1 August 2002
- Published by Elsevier in Clinical Immunology
- Vol. 104 (2) , 151-160
Glutamine Protects Activated Human T Cells from Apoptosis by Up-Regulating Glutathione and Bcl-2 Levels
- 1 August 2002
- Published by Elsevier in Clinical Immunology
- Vol. 104 (2) , 151-160
Glutamine Protects Activated Human T Cells from Apoptosis by Up-Regulating Glutathione and Bcl-2 Levels
- 22 February 2001
- Published by Wiley in Journal of Medical Virology
- Vol. 63 (2) , 150-157
Antibody‐dependent enhancement of heterotypic dengue infections involved in suppression of IFNγ production
- 22 February 2001
- Published by Wiley in Journal of Medical Virology
- Vol. 63 (2) , 150-157
Antibody‐dependent enhancement of heterotypic dengue infections involved in suppression of IFNγ production
- 1 August 1992
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 52 (2) , 151-156
Effects of phenobarbital on leukocyte activation: membrane potential, actin polymerization, chemotaxis, respiratory burst, cytokine production, and lymphocyte proliferation
Leukocyte activation is known to involve cell membrane potential changes. Phenobarbital, an anesthetic and anticonvulsant that can inhibit neuronal membrane depolarization, may also affect leukocyte activation. Measuring membrane potential, actin polymerization, chemotaxis, superoxide production, lymphocyte proliferation, intracellular calcium concentration, and cytokine production, we found that phenobarbital at a concentration of 15–30 μg/ml, which is considered a therapeutic serum level for controlling seizures, did not affect polymorphonuclear neutrophil (PMN) activation. At levels higher than 100 μg/ml, phenobarbital significantly suppressed formylmethionyl-leucyl-phenylalanine (fMLP)-induced chemotaxis. Concentrations greater than 300 μg/ml also inhibited phorbol myristate acetate–stimulated membrane potential change. In contrast, 30 fig/ml phenobarbital significantly inhibited lymphocyte proliferation stimulated by phytohemagglutinin (PHA) and pokeweed mitogen. This concentration of phenobarbital also suppressed the increase of intracellular free calcium induced by PHA. However, only a higher concentration of phenobarbital (300 μg/ml) was able to inhibit PHA-induced interleukin-2 (IL-2) production and suppress the proliferation of PHA-induced IL-2 receptor–bearing lymphocytes. These results suggest that concentrations of phenobarbital associated with anticonvulsive levels do not affect PMN activation but suppress lymphocyte activation, possibly by affecting intracellular signal transduction.
- 1 August 1992
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 52 (2) , 151-156
Effects of phenobarbital on leukocyte activation: membrane potential, actin polymerization, chemotaxis, respiratory burst, cytokine production, and lymphocyte proliferation
Leukocyte activation is known to involve cell membrane potential changes. Phenobarbital, an anesthetic and anticonvulsant that can inhibit neuronal membrane depolarization, may also affect leukocyte activation. Measuring membrane potential, actin polymerization, chemotaxis, superoxide production, lymphocyte proliferation, intracellular calcium concentration, and cytokine production, we found that phenobarbital at a concentration of 15–30 μg/ml, which is considered a therapeutic serum level for controlling seizures, did not affect polymorphonuclear neutrophil (PMN) activation. At levels higher than 100 μg/ml, phenobarbital significantly suppressed formylmethionyl-leucyl-phenylalanine (fMLP)-induced chemotaxis. Concentrations greater than 300 μg/ml also inhibited phorbol myristate acetate–stimulated membrane potential change. In contrast, 30 fig/ml phenobarbital significantly inhibited lymphocyte proliferation stimulated by phytohemagglutinin (PHA) and pokeweed mitogen. This concentration of phenobarbital also suppressed the increase of intracellular free calcium induced by PHA. However, only a higher concentration of phenobarbital (300 μg/ml) was able to inhibit PHA-induced interleukin-2 (IL-2) production and suppress the proliferation of PHA-induced IL-2 receptor–bearing lymphocytes. These results suggest that concentrations of phenobarbital associated with anticonvulsive levels do not affect PMN activation but suppress lymphocyte activation, possibly by affecting intracellular signal transduction.